Thursday, July 9, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Molecular Design International, Inc.”

5 pharma patents match "Molecular Design International, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "Molecular Design International, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “Molecular Design International, Inc.” · 30,257 patents in full index Clear search

  1. US 8912175

    Topical compositions for treatment of skin conditions

    Molecular Design International, Inc. · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  2. US 8865694

    Topical compositions for treatment of skin conditions

    Molecular Design International, Inc. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  3. US 7119103

    β3-Adrenoreceptor agonists, agonist compositions and methods of using

    Molecular Design International, Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted

  4. US 6919357

    α adrenergic agents

    Molecular Design International, Inc. · Granted Jul 19, 2005 · Expires Jul 14, 2025

    expired

  5. US 6825213

    &bgr;3-adrenoreceptor agonists, agonist compositions and methods of using

    Molecular Design International, Inc. · Granted Nov 30, 2004 · Expires Nov 25, 2024

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.